Total Funding
84
53
Total FundingGrant raised
Growth Score 84 in past quarter
-3 pts
Heat Score 53 in past quarter
-1 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
432119
Copernicus Therapeutics, Inc. (CTI) is a clinical stage biopharmaceutical company
- Thomas Ferkol: Co-Founder
- Robert Moen: President and CEO
About the Company
Copernicus Therapeutics, Inc. (CTI) is a clinical stage biopharmaceutical company and a leader in the emerging field of precision medicine and gene therapy. Through their proprietary, non-viral, nucleic acid nanoparticle platform, they are able to achieve robust gene transfer in several tissues without the immune response and limited treatment
window of AAV.